Q32 Bio Inc.

NASDAQ: QTTB · Real-Time Price · USD
1.98
0.10 (5.32%)
At close: Aug 15, 2025, 3:59 PM
1.98
-0.01%
After-hours: Aug 15, 2025, 05:53 PM EDT

Q32 Bio Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a -6.65M 6.65M 33.97M
Cost of Revenue
487K 578K 2.6M 9.54M
Gross Profit
-487K -7.23M 4.05M 24.43M
Operating Income
-66.1M -48.26M -39.23M -36.69M
Interest Income
3.9M n/a n/a n/a
Pretax Income
-46.09M -53.42M -42.75M -37.02M
Net Income
-47.73M -53.74M -42.81M -37.56M
Selling & General & Admin
17.47M 9.88M 10.06M 6.76M
Research & Development
48.14M 31.73M 35.81M 29.93M
Other Expenses
n/a n/a -1.12M -324K
Operating Expenses
65.61M 41.6M 45.88M 36.69M
Interest Expense
300K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-66.1M 41.6M 45.88M 36.69M
Income Tax Expense
21K 318K 62K 547K
Shares Outstanding (Basic)
9.32M 3.22M 3.19M 3.07M
Shares Outstanding (Diluted)
9.66M 3.22M 3.19M 3.07M
EPS (Basic)
-5.12 -16.7 -13.42 -12.23
EPS (Diluted)
-6.58 -16.7 -13.42 -12.23
EBITDA
-45.3M -47.76M -38.85M -86.22M
EBIT
-45.79M -48.26M -39.23M -95.76M
Depreciation & Amortization
487K 499K 2.6M 9.54M